JCM Symposium

JOHN C. MCDONALD TRANSPLANT & DIALYSIS

ACCESS SYMPOSIUM

LSU Health Sciences Center - Shreveport Department of Medicine Division of Nephrology

SATURDAY, NOVEMBER 1ST, 2014 HILTON SHREVEPORT 104 MARKET STREET

253
days
19
hours
54
min
45
sec

Welcome, we are proud to present the first Transplant and Dialysis Access Symposium in honor of Dr. John C. McDon-ald, MD (1930-2011). Recognized as a pio-neer in the field of or-gan transplantation, Dr. McDonald was Chancellor Emeritus of the Louisiana State University Health Sci-ences Center and former Dean of the LSU School of Medicine. He also served as the Chairman of the Department of Surgery from 1977-2000. Under his guidance, the first kidney transplant was performed at LSU Medical Center in April 1976. Since then, our transplant team has performed more than 2000 kidney, pancreas and liver transplants in Shreveport, LA. We are indebted to Dr. McDonald for his years of contibution and service to transplant recipients from Louisiana, Texas, Arkansas and Mississippi. The goal of this symopsium is to educate the health care professionals regarding new developments and complex issues in the management of dialysis and transplant patients. We hope that you can join us for our inaugural Transplant and Dialysis Acccess Symosium on No-vember 1st in Shreveport, LA.

2 AMAZING DIRECTORS

NEERAJ SINGH

NEERAJ SINGH

Associate Professor of Medicine Louisiana State University Health Medical Director, Kidney and Pancreas Transplant Program

BHARAT SACHDEVA

BHARAT SACHDEVA

Associate Professor of Medicine Program Director, Nephrology Fellowship Louisiana State University Health

 

2014 Recap

 

TimeEventsNameEvents [ Link ]
7.30 - 8.15 amREGISTRATION, BREAKFAST AND EXHIBITS
8.15 - 8.20 amWELCOME AND OVERVIEW
8.20 -10.00 am SESSION IWHAT’S NEW & WHAT’S HOT IN TRANSPLANT?MODERATORS:Kenneth Abreo MD
Gazi B. Zibari MD
8.20 - 8.40 amOrgan Shortage and AllocationGazi B. Zibari MDClick Here
8.40 - 9.00 amNewer ImmunosuppressionNeeraj Singh MDClick Here
9.00 - 9.20 amLiving Kidney Donation and OutcomesKenneth Abreo MDClick Here
9.20 - 9.40 amEconomics of Kidney TransplantJanea Matherly RNClick Here
9.40 -10.00 amPancreas Transplant for Type II Diabetes MellitusHosein Shoukouh Amiri MDClick Here
10.00 - 10.20 amBREAK AND EXHIBITS
10.20 - 12.00 am SESSION IIDIALYSIS ACCESS ISSUES IN ESRD PATIENTS MODERATORS:Raja Zabaneh MD
Joan Blondin MD
10.20 - 10.40 amWhen Should I Get an AVF for My CKD Patient?Karina Sulaiman MDClick Here
10.40 - 11.00 amPre surgical Evaluation for Dialysis Access and OutcomesHosein Shoukouh Amiri MDClick Here
11.00 - 11.20 amUrgent Start Peritoneal DialysisBharat Sachdeva MDClick Here
11.20 - 11.40 amAV Access When There Are Minimal OptionsAmy Coulter MDClick Here
11.40 - 12:00 pmNon Infectious Complications of Peritoneal DialysisMary Buffington MDClick Here
12.00 - 1.00 pmLUNCH AND EXHIBITS
1.00 - 3.20 pm SESSION III:CONTOVERSIES IN TRANSPLANT AND DIALYSIS ACCESS MODERATORS:Randal White MD DIALYSIS
Hosein Shoukouh Amiri MD
1.00 -1.20 pmWhen Is Access Flow Too High and What To Do About It?Adrian Sequeira MDClick Here
1.20 -1.40 pmThigh Grafts. Are They A Viable Access?Gazi B. Zibari MDClick Here
1.40 - 2.00 pmDialysis Access Surveillance: Medical Directors’ Perspective.Michael D Rokaw MDClick Here
2.00 - 2.20 pmDo Stents Have A Role In Vascular Access?Tze-Woei Tan MDClick Here
2.20 - 2.40 pmIs Parathyroidectomy Helpful Post Kidney Transplant?Donnie F. Aultman MDClick Here
2.40 - 3:00 pmLiver Transplant For MalignancyRobert McMillian MDClick Here
3.00 - 3.30 pmBREAK AND EXHIBITS
3.30 - 5.00 pm SESSION IVCASE BASED DISCUSSION MODERATORSBharat Sachdeva MD
Robert Mcmillan MD
3.30 - 3.45 pmA Kidney Transplant Recipient With Hypertension. What Are Some Of The Key Issues In Management?Zulqarnain Abro MDClick Here
3.45 - 4.00 pmA Kidney Transplant Recipient with a Cancer. What Is the Role of Cancer Screening Post-Transplant?Robert Nickelson MDClick Here
4.00 - 4.15 pmRecurrent Hepatitis C After Liver Transplant. How Do We Treat?David Dies MDClick Here
4.15 - 4.30 pmRole Of Vascular Access Coordinator: Do we really need one?Keri Lee RNClick Here
4.30 - 4.45 pmRecurrent AVG Thrombosis. Is Anticoagulation Required?Neville Dossabhoy MDClick Here
4.45 - 5.00 pmQ&A

LEARNING OBJECTIVES

  • Analyze new developments and controversial issues in kidney transplant.
  • Discuss the therapeutic strategies in patients with complex kidney Transplant issues
  • Analyze the importance of vascular access in end-stage renal disease.
  • Discuss creation and maintainaince for optimal performance of vascular access

TARGET AUDIENCE

 

 

 

 

 

The course is designed to help healthcare pro-viders caring for patients with solid abdominal organ transplants and end stage renal disease, including but not limited to transplant surgeons and physicians, nephrologists, physician assistants, nurses, nurse prac-tioners, and fellows.

 

CME ACCREDITATION & CREDIT DESIGNATION

  • Louisiana State University Health Sciences Center-Shreve-port, School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
  • Louisiana State University Health Sciences Center-Shreve-port, School of Medicine designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING ACCREDITATION

  •  

     

     

    7.0 contact hours of continuing education credit will be awarded to Registrered Nurses upon successful completion of this offering.

     

     

     

     

     

  •  

     

     

    University Health Shreveport is an approved provider of continuing nursing education by the South Central Accreditation Program, an accredited approver by the American Nurses credentialing Center’s Commission on Accreditation.